leadf
logo-loader
viewIntegumen

Full interview: Integumen's Gerry Brandon discusses launch of Rinodrive AI platform

Integumen PLC's (LON:SKIN) Gerry Brandon tells Proactive London's Andrew Scott they're looking to add new revenue-sharing deals following the launch of Rinodrive.

Brandon says it's an independent Artificial Intelligent platform for collaboration and joint venture partners as an open-source cloud-based eco-system.

He adds it's already being rolled out and tested by existing Integumen healthcare clients, a number of universities, government departments, in one UK bank and an international financial advisory firm.

Quick facts: Integumen

Price: 35.33 GBX

AIM:SKIN
Market: AIM
Market Cap: £39.61 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Integumen PLC to seek fast-track approval for its new coronavirus breath test

Integumen PLC's (LON:SKIN) Gerry Brandon speaks to Proactive's Andrew Scott after unveiling a new personalised coronavirus breath test, Microtox BT, and a complimentary digital health pass platform which he says has the potential to enable instant real-time testing for the virus. Brandon says...

4 days ago

2 min read